Uthman Okikiola Adebayo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Uthman Okikiola Adebayo has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Olalekan John Okesanya
Department of Medical Laboratory Science Neuropsychiatric Hospital, Aro Abeokuta Nigeria
36 shared publications - Mohamed Mustaf Ahmed
Faculty of Medicine and Health Sciences SIMAD University Mogadishu Somalia
32 shared publications - Don Eliseo Lucero-Prisno
London School of Hygiene and Tropical Medicine
28 shared publications - Tolutope Adebimpe Oso
Department of Medical Laboratory Science, Neuropsychiatric Hospital, Aro, Abeokuta 110101, Ogun State, Nigeria; Department of Medical Laboratory Science, McPherson University, Seriki Sotayo 110117, Ogun State, Nigeria
23 shared publications - Oluwatobi Babajide Ayelaagbe
Department of Medical Laboratory Science, Neuropsychiatric Hospital, Abeokuta, Nigeria
16 shared publications Tolutope Adebimpe Oso
10 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Oxford University Press (OUP) in International Health
Bridging healthcare gaps through public–private partnerships in Nigeria: a scoping review
Nigeria’s healthcare system faces several persistent structural challenges. Public–private partnerships (PPPs) have emerged as a strategy to address these gaps, although evidence on their implementation and impact remains fragmented. This scoping review mapped the implementation models, outcomes, challenges and future directions of PPPs in Nigeria’s healthcare system, following the Arksey and O’Malley framework and PRISMA-ScR guidelines. Literature searches were conducted across PubMed, Scopus, Web of Science, Google Scholar and grey literature sources. Studies were screened using Rayyan, while eligibility was guided by the population–concept–context framework. Data were synthesized using descriptive and thematic analysis. Twenty-four studies were included, covering PPP applications across primary, secondary, tertiary and community healthcare systems. Identified models included service delivery, financing, infrastructure, supply chain and governance partnerships. The included evidence reported improvements in healthcare access, diagnostic capacity, immunization coverage, infrastructure development and system efficiency, particularly in tuberculosis diagnostics, radiology, dialysis and radiotherapy services. However, weak governance, poor stakeholder coordination, funding instability, affordability barriers and inequitable urban concentration of benefits persisted. Strengthening regulatory frameworks, sustainable financing, accountability and equitable access may enhance PPP implementation and enable appropriately governed PPPs to contribute to selected dimensions of healthcare access and service capacity relevant to universal health coverage in Nigeria.
- 7 October 2026
- Published by Oxford University Press (OUP) in International Health
Open AccessBridging healthcare gaps through public–private partnerships in Nigeria: a scoping review
Nigeria’s healthcare system faces several persistent structural challenges. Public–private partnerships (PPPs) have emerged as a strategy to address these gaps, although evidence on their implementation and impact remains fragmented. This scoping review mapped the implementation models, outcomes, challenges and future directions of PPPs in Nigeria’s healthcare system, following the Arksey and O’Malley framework and PRISMA-ScR guidelines. Literature searches were conducted across PubMed, Scopus, Web of Science, Google Scholar and grey literature sources. Studies were screened using Rayyan, while eligibility was guided by the population–concept–context framework. Data were synthesized using descriptive and thematic analysis. Twenty-four studies were included, covering PPP applications across primary, secondary, tertiary and community healthcare systems. Identified models included service delivery, financing, infrastructure, supply chain and governance partnerships. The included evidence reported improvements in healthcare access, diagnostic capacity, immunization coverage, infrastructure development and system efficiency, particularly in tuberculosis diagnostics, radiology, dialysis and radiotherapy services. However, weak governance, poor stakeholder coordination, funding instability, affordability barriers and inequitable urban concentration of benefits persisted. Strengthening regulatory frameworks, sustainable financing, accountability and equitable access may enhance PPP implementation and enable appropriately governed PPPs to contribute to selected dimensions of healthcare access and service capacity relevant to universal health coverage in Nigeria.
- Open Access
- 29 September 2026
- Published by Wiley in Public Health Challenges
- Vol. 5 (4) , e70388
The Kush Drug Epidemic in Sierra Leone: Public Health Implications, Socioeconomic Drivers and Health System Responses
Background: Kush, a synthetic drug combining cannabinoids and nitazene opioids, has emerged as a major public health concern in Sierra Leone, with reported prevalence and clinical severity increasing markedly as it was first identified. This review examines the health consequences of Kush use, the socioeconomic and structural drivers underpinning its spread, and the adequacy of health system and policy responses across the Mano River Basin. Methods: A narrative review was conducted using structured searches of PubMed/MEDLINE, Scopus, Web of Science and Google Scholar (2016–2025). Grey literature, including government policy documents, reports from international organisations, civil society publications and credible media sources, was systematically reviewed. Eligible sources addressed Kush or related synthetic drug use in Sierra Leone and the wider West African subregion, with emphasis on health outcomes, socioeconomic determinants, health system capacity and policy responses. Results: Kush exhibits unpredictable toxicity and high dependence potential, with documented associations including acute psychosis, cognitive impairment, severe morbidity and rising mortality. Weak surveillance systems likely underestimate its burden. Structural drivers include entrenched youth unemployment, poverty, rapid urbanisation, post‐conflict trauma and limited access to education and mental health services. Regional dynamics across Sierra Leone, Liberia, Guinea and The Gambia reinforce its transnational spread. Responses since 2024 have intensified but remain disproportionately focused on law enforcement, whereas prevention, treatment and workforce development remain critically under‐resourced. Conclusion: The Kush crisis exemplifies a complex, cross‐border public health emergency. Addressing it requires integrated, evidence‐informed strategies that strengthen health systems, expand community‐based interventions, improve toxicological surveillance and enhance regional coordination under ECOWAS frameworks.
- 29 September 2026
- Published by Wiley in Public Health Challenges
- Vol. 5 (4) , e70388
Open AccessThe Kush Drug Epidemic in Sierra Leone: Public Health Implications, Socioeconomic Drivers and Health System Responses
Background: Kush, a synthetic drug combining cannabinoids and nitazene opioids, has emerged as a major public health concern in Sierra Leone, with reported prevalence and clinical severity increasing markedly as it was first identified. This review examines the health consequences of Kush use, the socioeconomic and structural drivers underpinning its spread, and the adequacy of health system and policy responses across the Mano River Basin. Methods: A narrative review was conducted using structured searches of PubMed/MEDLINE, Scopus, Web of Science and Google Scholar (2016–2025). Grey literature, including government policy documents, reports from international organisations, civil society publications and credible media sources, was systematically reviewed. Eligible sources addressed Kush or related synthetic drug use in Sierra Leone and the wider West African subregion, with emphasis on health outcomes, socioeconomic determinants, health system capacity and policy responses. Results: Kush exhibits unpredictable toxicity and high dependence potential, with documented associations including acute psychosis, cognitive impairment, severe morbidity and rising mortality. Weak surveillance systems likely underestimate its burden. Structural drivers include entrenched youth unemployment, poverty, rapid urbanisation, post‐conflict trauma and limited access to education and mental health services. Regional dynamics across Sierra Leone, Liberia, Guinea and The Gambia reinforce its transnational spread. Responses since 2024 have intensified but remain disproportionately focused on law enforcement, whereas prevention, treatment and workforce development remain critically under‐resourced. Conclusion: The Kush crisis exemplifies a complex, cross‐border public health emergency. Addressing it requires integrated, evidence‐informed strategies that strengthen health systems, expand community‐based interventions, improve toxicological surveillance and enhance regional coordination under ECOWAS frameworks.
- Open Access
- 28 September 2026
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 21 (5) , 1007-1028
Prevalence and burden of HIV–TB co-infection among pregnant women: A systematic review and meta-analysis
- 28 September 2026
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 21 (5) , 1007-1028
Open AccessPrevalence and burden of HIV–TB co-infection among pregnant women: A systematic review and meta-analysis
- Open Access
- 22 September 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1)
Molecular pathogenesis, global epidemiological trends, and treatment strategies for pteropine orthoreoviruses: a narrative review
Zoonotic viruses from wildlife reservoirs remain a persistent public-health threat [1]. Bats are particularly important reservoirs because they host diverse viruses and often tolerate infection, li...
- 22 September 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1)
Open AccessMolecular pathogenesis, global epidemiological trends, and treatment strategies for pteropine orthoreoviruses: a narrative review
Zoonotic viruses from wildlife reservoirs remain a persistent public-health threat [1]. Bats are particularly important reservoirs because they host diverse viruses and often tolerate infection, li...
- Open Access
- 15 September 2026
- Published by Wiley in Public Health Challenges
- Vol. 5 (3) , e70372
Top 10 Public Health Challenges in 2025: Lessons and Priorities for 2025–2030
By 2025, global public health will be shaped by interconnected and intensifying threats that demand coordinated international action. Ten key public health challenges were identified and examined. This perspective reviews the challenges that shaped 2025 and the priorities set for the period 2025–2030, using evidence available up to July 2026; therefore, it is in part a retrospective assessment of that year rather than solely a prospective identification of challenges at its outset. The designation of the Top 10 denotes prominence and salience rather than a strict ordinal ranking. The challenges selected for this year include drug‐resistant infections, health consequences of a warming planet, rising rates of psychological distress, persistent burden of long‐term diseases and health inequities, preparedness for future disease outbreaks, widespread hunger and poor nutrition, shortages of doctors and nurses, harmful use of alcohol and drugs, barriers to reproductive and sexual well‐being, and ethical questions raised by the growing role of computing and data‐driven tools in medicine. Each challenge was examined in terms of its current scope, the populations most affected, and the strategies needed to mount an effective response to it. The analysis draws out the cross‐cutting links among the 10 challenges and sets out a proposed agenda for action for 2025–2030. The adoption of the World Health Organization Pandemic Agreement by the World Health Assembly in May 2025 established an important framework for future cooperation, although the agreement had not been opened for signature and had not entered into force at the time of writing, and progress across most indicators continued to fall short of global targets. Pressures that intensified in 2025, notably the retrenchment of international health financing and the rapid clinical adoption of artificial intelligence ahead of rigorous evaluation, further sharpened several of these challenges.
- 15 September 2026
- Published by Wiley in Public Health Challenges
- Vol. 5 (3) , e70372
Open AccessTop 10 Public Health Challenges in 2025: Lessons and Priorities for 2025–2030
By 2025, global public health will be shaped by interconnected and intensifying threats that demand coordinated international action. Ten key public health challenges were identified and examined. This perspective reviews the challenges that shaped 2025 and the priorities set for the period 2025–2030, using evidence available up to July 2026; therefore, it is in part a retrospective assessment of that year rather than solely a prospective identification of challenges at its outset. The designation of the Top 10 denotes prominence and salience rather than a strict ordinal ranking. The challenges selected for this year include drug‐resistant infections, health consequences of a warming planet, rising rates of psychological distress, persistent burden of long‐term diseases and health inequities, preparedness for future disease outbreaks, widespread hunger and poor nutrition, shortages of doctors and nurses, harmful use of alcohol and drugs, barriers to reproductive and sexual well‐being, and ethical questions raised by the growing role of computing and data‐driven tools in medicine. Each challenge was examined in terms of its current scope, the populations most affected, and the strategies needed to mount an effective response to it. The analysis draws out the cross‐cutting links among the 10 challenges and sets out a proposed agenda for action for 2025–2030. The adoption of the World Health Organization Pandemic Agreement by the World Health Assembly in May 2025 established an important framework for future cooperation, although the agreement had not been opened for signature and had not entered into force at the time of writing, and progress across most indicators continued to fall short of global targets. Pressures that intensified in 2025, notably the retrenchment of international health financing and the rapid clinical adoption of artificial intelligence ahead of rigorous evaluation, further sharpened several of these challenges.
- Open Access
- 6 September 2026
- Published by SAGE Publications in Environmental Health Insights
- Vol. 20
Perceived Work-Related Health Effects and Associated Factors Among Grinding Workers in Sagamu, Nigeria: A Cross-Sectional Study
Background: Workers in informal grinding industries are frequently exposed to multiple occupational hazards, yet data on their self-reported health effects remain limited. Understanding these perceptions is critical for designing practical preventive interventions in resource-limited settings. Objective: To determine the prevalence and associated factors of self-reported health effects among commercial grinding workers in Sagamu, Ogun State, Nigeria. Methods: A cross-sectional study was conducted among 347 randomly selected commercial grinding workers in Sagamu, Nigeria, from January to September 2025. Data were collected using an interviewer-administered questionnaire and analysed using descriptive statistics, chi-square tests, and multivariable logistic regression in SPSS version 25 (p < 0.05). The response rate could not be determined because the number of eligible workers approached was not documented. Results: Overall, 82.4% of respondents reported health effects, most commonly hearing difficulty (19.9%), respiratory symptoms (16.4%), and musculoskeletal discomfort (16.4%). Longer work experience (AOR = 1.10; 95% CI: 1.03–1.17), longer working hours (AOR = 1.14; 95% CI: 1.02–1.29), and smoking (AOR = 1.62; 95% CI: 1.05–2.56) were associated with higher odds of self-reported health effects, while Personal Protective Equipment (PPE) use was associated with lower odds (AOR = 0.39; 95% CI: 0.21–0.72). Conclusion: Self-reported health effects were common among grinding workers, particularly hearing, respiratory, and musculoskeletal symptoms. Longer work experience, working hours, smoking, and PPE use were associated with reported health effects. Further studies using objective exposure and clinical assessments are warranted.
- 6 September 2026
- Published by SAGE Publications in Environmental Health Insights
- Vol. 20
Open AccessPerceived Work-Related Health Effects and Associated Factors Among Grinding Workers in Sagamu, Nigeria: A Cross-Sectional Study
Background: Workers in informal grinding industries are frequently exposed to multiple occupational hazards, yet data on their self-reported health effects remain limited. Understanding these perceptions is critical for designing practical preventive interventions in resource-limited settings. Objective: To determine the prevalence and associated factors of self-reported health effects among commercial grinding workers in Sagamu, Ogun State, Nigeria. Methods: A cross-sectional study was conducted among 347 randomly selected commercial grinding workers in Sagamu, Nigeria, from January to September 2025. Data were collected using an interviewer-administered questionnaire and analysed using descriptive statistics, chi-square tests, and multivariable logistic regression in SPSS version 25 (p < 0.05). The response rate could not be determined because the number of eligible workers approached was not documented. Results: Overall, 82.4% of respondents reported health effects, most commonly hearing difficulty (19.9%), respiratory symptoms (16.4%), and musculoskeletal discomfort (16.4%). Longer work experience (AOR = 1.10; 95% CI: 1.03–1.17), longer working hours (AOR = 1.14; 95% CI: 1.02–1.29), and smoking (AOR = 1.62; 95% CI: 1.05–2.56) were associated with higher odds of self-reported health effects, while Personal Protective Equipment (PPE) use was associated with lower odds (AOR = 0.39; 95% CI: 0.21–0.72). Conclusion: Self-reported health effects were common among grinding workers, particularly hearing, respiratory, and musculoskeletal symptoms. Longer work experience, working hours, smoking, and PPE use were associated with reported health effects. Further studies using objective exposure and clinical assessments are warranted.
- Open Access
- 29 August 2026
- Published by Springer Nature in Patient Safety in Surgery
Current cybersecurity threats to patient safety in the operating room: a review
Surgical, anesthetic, and intensive care practices now depend on a large ecosystem of wired and wireless devices, robotic consoles, imaging and laboratory systems, and cloud infrastructure: the Internet of Medical Things and the smart operating room, which extends care beyond the physical theatre to transcontinental telesurgery. Connectivity that is useful in routine care becomes a failure mode during a cyber incident because surgical pathways depend on uninterrupted access to scheduling, imaging, electronic records, and device data. This narrative review sets out the architecture of the surgical Internet of Medical Things and the main threat categories: ransomware, supply chain and firmware compromise, wireless interception, attacks on teleoperated robotic systems, and insider or workforce-related exposure. It then examines documented incidents at the hospital, emergency, and procedural levels, together with the vulnerability profiles of robotic surgical platforms, cardiac implantable electronic devices, infusion systems, and perioperative monitors. Reported harms include cancelled admissions, interrupted cancer surgery and radiotherapy, and worse outcomes after out-of-hospital cardiac arrest, although most of this evidence is healthcare-wide or device-class specific rather than surgery-specific. Although regulatory and governance responses are strengthening, they remain fragmented. The review highlights secure design engineering, human factors, workforce readiness, specialty-specific threat models, and registries as priorities and draws out what each implies for surgeons, anesthetists, device manufacturers, regulators, and hospital leaders.
- 29 August 2026
- Published by Springer Nature in Patient Safety in Surgery
Open AccessCurrent cybersecurity threats to patient safety in the operating room: a review
Surgical, anesthetic, and intensive care practices now depend on a large ecosystem of wired and wireless devices, robotic consoles, imaging and laboratory systems, and cloud infrastructure: the Internet of Medical Things and the smart operating room, which extends care beyond the physical theatre to transcontinental telesurgery. Connectivity that is useful in routine care becomes a failure mode during a cyber incident because surgical pathways depend on uninterrupted access to scheduling, imaging, electronic records, and device data. This narrative review sets out the architecture of the surgical Internet of Medical Things and the main threat categories: ransomware, supply chain and firmware compromise, wireless interception, attacks on teleoperated robotic systems, and insider or workforce-related exposure. It then examines documented incidents at the hospital, emergency, and procedural levels, together with the vulnerability profiles of robotic surgical platforms, cardiac implantable electronic devices, infusion systems, and perioperative monitors. Reported harms include cancelled admissions, interrupted cancer surgery and radiotherapy, and worse outcomes after out-of-hospital cardiac arrest, although most of this evidence is healthcare-wide or device-class specific rather than surgery-specific. Although regulatory and governance responses are strengthening, they remain fragmented. The review highlights secure design engineering, human factors, workforce readiness, specialty-specific threat models, and registries as priorities and draws out what each implies for surgeons, anesthetists, device manufacturers, regulators, and hospital leaders.
- Open Access
- 18 August 2026
- Published by Open Exploration Publishing in Exploration of Drug Science
- Vol. 4, 1008177
Cannabinoid therapeutics in the 21st century: from molecular mechanisms to equitable clinical integration
Cannabis sativa has a long history in ethnomedicine, but advances in molecular biology and regulatory shifts have reignited global interest in its therapeutic potential. Cannabinoid research in the 21st century spans molecular pharmacology, clinical applications, and public health integration. This study provides a comprehensive synthesis of the current state of knowledge. This narrative review synthesizes evidence from Scopus, PubMed, and Google Scholar using Medical Subject Headings-based search strategies. Only articles published in English were included, without restrictions on publication year; however, greater emphasis was placed on recent studies to ensure currency, while seminal and historically important publications were included where necessary to provide foundational context. Relevant studies were thematically analyzed and summarized under predefined headings. Major phytocannabinoids have been identified, with Δ9-tetrahydrocannabinol, cannabidiol, and cannabigerol as key therapeutic candidates. Preclinical studies have shown neuroprotective, anti-inflammatory, analgesic, immunomodulatory, and anticancer effects, but clinical translation remains limited by variability, dosing challenges, and inconsistent reproducibility. These effects are mediated through the endocannabinoid system and related receptor networks. Emerging evidence suggests that epigenetic regulation and precision medicine approaches may enhance individualized cannabinoid therapy. However, safety concerns, including cognitive and psychiatric effects, drug interactions, and dependence, require robust pharmacovigilance. Fragmented regulatory frameworks continue to hinder research and equitable access, underscoring the need for standardized formulations, clinician training, and equity-focused integration into health systems. Cannabinoid therapeutics represent a rapidly evolving field with promise in multiple medical domains. Future progress hinges on harmonizing regulations, expanding clinical evidence, and integrating precision medicine, equity, and public health principles to maximize therapeutic benefits while minimizing risks.
- 18 August 2026
- Published by Open Exploration Publishing in Exploration of Drug Science
- Vol. 4, 1008177
Open AccessCannabinoid therapeutics in the 21st century: from molecular mechanisms to equitable clinical integration
Cannabis sativa has a long history in ethnomedicine, but advances in molecular biology and regulatory shifts have reignited global interest in its therapeutic potential. Cannabinoid research in the 21st century spans molecular pharmacology, clinical applications, and public health integration. This study provides a comprehensive synthesis of the current state of knowledge. This narrative review synthesizes evidence from Scopus, PubMed, and Google Scholar using Medical Subject Headings-based search strategies. Only articles published in English were included, without restrictions on publication year; however, greater emphasis was placed on recent studies to ensure currency, while seminal and historically important publications were included where necessary to provide foundational context. Relevant studies were thematically analyzed and summarized under predefined headings. Major phytocannabinoids have been identified, with Δ9-tetrahydrocannabinol, cannabidiol, and cannabigerol as key therapeutic candidates. Preclinical studies have shown neuroprotective, anti-inflammatory, analgesic, immunomodulatory, and anticancer effects, but clinical translation remains limited by variability, dosing challenges, and inconsistent reproducibility. These effects are mediated through the endocannabinoid system and related receptor networks. Emerging evidence suggests that epigenetic regulation and precision medicine approaches may enhance individualized cannabinoid therapy. However, safety concerns, including cognitive and psychiatric effects, drug interactions, and dependence, require robust pharmacovigilance. Fragmented regulatory frameworks continue to hinder research and equitable access, underscoring the need for standardized formulations, clinician training, and equity-focused integration into health systems. Cannabinoid therapeutics represent a rapidly evolving field with promise in multiple medical domains. Future progress hinges on harmonizing regulations, expanding clinical evidence, and integrating precision medicine, equity, and public health principles to maximize therapeutic benefits while minimizing risks.
- Open Access
- 3 August 2026
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 54 (1) , 135
Advanced statistical approaches in tuberculosis diagnosis and treatment outcomes in Africa: a systematic review
Background: Tuberculosis (TB) remains a major public health challenge in Africa; however, conventional statistical approaches often fail to capture diagnostic uncertainty, spatial heterogeneity, and complex disease dynamics, limiting evidence-based decision-making. This review synthesizes the application and performance of advanced statistical and computational methods for TB diagnosis and treatment outcomes in Africa. Methods: Following the PRISMA 2020 guidelines, we systematically searched PubMed and Scopus for peer-reviewed studies (2010–2025) conducted in Africa that applied advanced methods, including Bayesian models, machine learning (ML) algorithms, spatiotemporal analyses, time-series models, and multistate or survival frameworks. Study selection, data extraction, and quality appraisal were independently conducted by multiple reviewers using the Joanna Briggs Institute tools. Findings were synthesized narratively because of substantial methodological heterogeneity. Results: Twenty-seven studies from nine African countries were included. Bayesian hierarchical, geostatistical, and latent class models improved estimation of TB incidence, mortality, and diagnostic accuracy by accounting for uncertainty, imperfect reference standards, and sparse data. Spatiotemporal analyses consistently identified geographic TB and TB–HIV hotspots linked to low Bacillus Calmette–Guérin vaccine coverage, illiteracy, and urban crowding as risk factors. Time-series models quantified the significant decline in TB notifications during the COVID-19 disruptions. ML approaches, particularly random forests, outperformed traditional regression in predicting latent TB infection and treatment outcomes. Drug resistance, notably to bedaquiline and levofloxacin, showed clear spatial clustering and dynamic progression patterns. Conclusions: Advanced statistical and computational methods are increasingly improving TB diagnosis, prognosis, and treatment insights in Africa by capturing complex patterns beyond classical models, but their broader impact is limited by data gaps, heterogeneity, and insufficient validation, highlighting the need for high-quality, multi-country research and stronger implementation frameworks. PROSPERO ID: CRD420251160248
- 3 August 2026
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 54 (1) , 135
Open AccessAdvanced statistical approaches in tuberculosis diagnosis and treatment outcomes in Africa: a systematic review
Background: Tuberculosis (TB) remains a major public health challenge in Africa; however, conventional statistical approaches often fail to capture diagnostic uncertainty, spatial heterogeneity, and complex disease dynamics, limiting evidence-based decision-making. This review synthesizes the application and performance of advanced statistical and computational methods for TB diagnosis and treatment outcomes in Africa. Methods: Following the PRISMA 2020 guidelines, we systematically searched PubMed and Scopus for peer-reviewed studies (2010–2025) conducted in Africa that applied advanced methods, including Bayesian models, machine learning (ML) algorithms, spatiotemporal analyses, time-series models, and multistate or survival frameworks. Study selection, data extraction, and quality appraisal were independently conducted by multiple reviewers using the Joanna Briggs Institute tools. Findings were synthesized narratively because of substantial methodological heterogeneity. Results: Twenty-seven studies from nine African countries were included. Bayesian hierarchical, geostatistical, and latent class models improved estimation of TB incidence, mortality, and diagnostic accuracy by accounting for uncertainty, imperfect reference standards, and sparse data. Spatiotemporal analyses consistently identified geographic TB and TB–HIV hotspots linked to low Bacillus Calmette–Guérin vaccine coverage, illiteracy, and urban crowding as risk factors. Time-series models quantified the significant decline in TB notifications during the COVID-19 disruptions. ML approaches, particularly random forests, outperformed traditional regression in predicting latent TB infection and treatment outcomes. Drug resistance, notably to bedaquiline and levofloxacin, showed clear spatial clustering and dynamic progression patterns. Conclusions: Advanced statistical and computational methods are increasingly improving TB diagnosis, prognosis, and treatment insights in Africa by capturing complex patterns beyond classical models, but their broader impact is limited by data gaps, heterogeneity, and insufficient validation, highlighting the need for high-quality, multi-country research and stronger implementation frameworks. PROSPERO ID: CRD420251160248
- Open Access
- 30 July 2026
- Published by IntechOpen
Perspective Chapter: AI-driven Mobile Triage and Referral Systems to Transform Primary and Emergency Care in Resource-Limited Settings
This chapter addresses the use of mobile health technologies for the improvement of healthcare systems in low- and middle-income countries. Recent years have seen an increasing application of artificial intelligence (AI) in mHealth for redesigning triage and referral systems to minimize delays and reduce mis-triage-related mortality in resource-constrained healthcare systems. This chapter describes how smartphone-based decision-support systems, chatbots, and integrated referral systems can support healthcare workers and community health workers in the timely identification of high-risk patients and in prioritizing emergency cases, including maternal and child health cases. These systems also support the referral of patients in a timely and safe manner to higher-level healthcare facilities. Evidence on the use of mHealth-based triage and referral systems is summarized from low- and middle-income countries. Experiences with the use of these systems in fragile and conflict-affected health systems are also presented. The chapter also discusses the issue of interoperability of these systems with national digital health systems. Ethical, equity, and governance issues that need to be addressed when scaling up mHealth-based AI-powered triage systems are also presented. Recommendations are made for policy makers, clinicians, and mobile health application developers.
- 30 July 2026
- Published by IntechOpen
Open AccessPerspective Chapter: AI-driven Mobile Triage and Referral Systems to Transform Primary and Emergency Care in Resource-Limited Settings
This chapter addresses the use of mobile health technologies for the improvement of healthcare systems in low- and middle-income countries. Recent years have seen an increasing application of artificial intelligence (AI) in mHealth for redesigning triage and referral systems to minimize delays and reduce mis-triage-related mortality in resource-constrained healthcare systems. This chapter describes how smartphone-based decision-support systems, chatbots, and integrated referral systems can support healthcare workers and community health workers in the timely identification of high-risk patients and in prioritizing emergency cases, including maternal and child health cases. These systems also support the referral of patients in a timely and safe manner to higher-level healthcare facilities. Evidence on the use of mHealth-based triage and referral systems is summarized from low- and middle-income countries. Experiences with the use of these systems in fragile and conflict-affected health systems are also presented. The chapter also discusses the issue of interoperability of these systems with national digital health systems. Ethical, equity, and governance issues that need to be addressed when scaling up mHealth-based AI-powered triage systems are also presented. Recommendations are made for policy makers, clinicians, and mobile health application developers.